Edward Morrow Atkinson III - Jun 1, 2023 Form 4 Insider Report for 89bio, Inc. (ETNB)

Role
Director
Signature
/s/ Ryan A. Murr, as attorney-in-fact for Edward Morrow Atkinson III
Stock symbol
ETNB
Transactions as of
Jun 1, 2023
Transactions value $
-$95,625
Form type
4
Date filed
6/5/2023, 05:03 PM
Previous filing
Mar 3, 2023
Next filing
Sep 5, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ETNB Common Stock Options Exercise $16.3K +6.25K $2.61* 6.25K Jun 1, 2023 Direct
transaction ETNB Common Stock Sale -$112K -6.25K -100% $17.91 0 Jun 1, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ETNB Stock Option (Right to Buy) Options Exercise $0 -6.25K -100% $0.00* 0 Jun 1, 2023 Common Stock 6.25K $2.61 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on January 30, 2023 in multiple trades at prices ranging from $17.53 to $18.18. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
F2 This option represents a right to purchase a total of 6,250 shares of the Issuer's Common Stock, which vested in full on May 16, 2023.